CLINICAL_TRIALS
trial_result
· 2024-11-21
Clinical Trial Update: Effect of Fucoxanthin on the Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion [Phase 2]
Summary
Phase 2 trial evaluating fucoxanthin for metabolic syndrome has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Guadalajara | Conditions: Metabolic Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2024-11-21